Literature DB >> 16550468

Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.

Koji Yamaguchi1, Tetsuya Mitsui, Toshinori Yamamoto, Rie Shiokawa, Yuko Nomiyama, Norihisa Ohishi, Yoshinori Aso, Kenji Sugibayashi.   

Abstract

PURPOSE: The purpose of this study is to analyze simultaneous skin permeation and metabolism of 22-oxacalcitriol (OCT) having several metabolites in skin by observing skin permeation of only unchanged OCT through excised rat skin.
METHODS: A diffusion model including metabolic processes was employed to express simultaneous skin permeation and metabolism of OCT. In vitro permeation experiments of OCT from Oxarol ointment through full-thickness and stripped rat skin were carried out using Franz-type diffusion cells. Time courses of unchanged OCT amounts in ointment, skin, and receptor fluid were determined and fitted to diffusion equations to obtain permeation parameters and a metabolic rate.
RESULTS: Fitting curves of the skin permeation profile obtained by the model were sufficiently close to observed data of unchanged OCT amounts in ointment, skin, and receptor fluid. The following parameters were obtained: metabolic rate of 1.37 x 10(-1) h(-1), and diffusion constants of OCT in stratum corneum (SC) (D(SC)) and viable epidermis and dermis (VED) (D(VED)) of 1.50 x 10(-7) and 2.96 x 10(-4) cm2/h, respectively. The partition coefficient of OCT for SC/ointment (K(SC/D)) was 7 times greater than that of VED/ointment (K(VED/D)).
CONCLUSIONS: The present analysis made it possible to calculate skin permeation parameters (partitioning, diffusivity, and metabolic rate) of OCT without requiring metabolic information, e.g., quantification of metabolites or identification of metabolic pathways. This would be widely applicable for drugs that are not suitable for conventional methods due to complicated metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550468     DOI: 10.1007/s11095-006-9781-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia.

Authors:  J Abe; M Morikawa; K Miyamoto; S Kaiho; M Fukushima; C Miyaura; E Abe; T Suda; Y Nishii
Journal:  FEBS Lett       Date:  1987-12-21       Impact factor: 4.124

2.  Analysis of drug penetration through skin considering donor concentration decrease.

Authors:  M Hashida; H Okamoto; H Sezaki
Journal:  J Pharmacobiodyn       Date:  1988-09

3.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development.

Authors:  C D Yu; J L Fox; N F Ho; W I Higuchi
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

4.  Physical model relating diffusional transport and concurrent metabolism of peptides in metabolically active cell sheets.

Authors:  I Steinsträsser; R Sperb; H P Merkle
Journal:  J Pharm Sci       Date:  1995-11       Impact factor: 3.534

5.  Diffusion and metabolism of prednisolone farnesylate in viable skin of the hairless mouse.

Authors:  K Tojo; K Yamada; T Hikima
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

6.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

7.  Modeling of diffusion and concurrent metabolism in cutaneous tissue.

Authors:  P Boderke; K Schittkowski; M Wolf; H P Merkle
Journal:  J Theor Biol       Date:  2000-06-07       Impact factor: 2.691

8.  Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.

Authors:  J N Barker; R E Ashton; R Marks; R I Harris; J Berth-Jones
Journal:  Br J Dermatol       Date:  1999-08       Impact factor: 9.302

9.  Metabolism of propranolol during percutaneous absorption in human skin.

Authors:  J I Ademola; C A Chow; R C Wester; H I Maibach
Journal:  J Pharm Sci       Date:  1993-08       Impact factor: 3.534

10.  Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone.

Authors:  J Kao; F K Patterson; J Hall
Journal:  Toxicol Appl Pharmacol       Date:  1985-12       Impact factor: 4.219

View more
  1 in total

Review 1.  Surging footprints of mathematical modeling for prediction of transdermal permeability.

Authors:  Neha Goyal; Purva Thatai; Bharti Sapra
Journal:  Asian J Pharm Sci       Date:  2017-02-22       Impact factor: 6.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.